Precigen (PGEN) EPS (Weighted Average and Diluted): 2019-2024

Historic EPS (Weighted Average and Diluted) for Precigen (PGEN) over the last 6 years, with Dec 2024 value amounting to -$0.47.

  • Precigen's EPS (Weighted Average and Diluted) fell 1077.78% to -$1.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.39, marking a year-over-year decrease of 152.73%. This contributed to the annual value of -$0.47 for FY2024, which is 20.51% down from last year.
  • Latest data reveals that Precigen reported EPS (Weighted Average and Diluted) of -$0.47 as of FY2024, which was down 20.51% from -$0.39 recorded in FY2023.
  • In the past 5 years, Precigen's EPS (Weighted Average and Diluted) ranged from a high of -$0.39 in FY2023 and a low of -$1.02 during FY2020.
  • Over the past 3 years, Precigen's median EPS (Weighted Average and Diluted) value was -$0.40 (recorded in 2022), while the average stood at -$0.42.
  • As far as peak fluctuations go, Precigen's EPS (Weighted Average and Diluted) skyrocketed by 51.20% in 2020, and later declined by 20.51% in 2024.
  • Precigen's EPS (Weighted Average and Diluted) (Yearly) stood at -$1.02 in 2020, then skyrocketed by 45.10% to -$0.56 in 2021, then climbed by 28.57% to -$0.40 in 2022, then climbed by 2.50% to -$0.39 in 2023, then dropped by 20.51% to -$0.47 in 2024.